Skip to content

Clinical trials

Thyroid Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Country / region: United States Clear all

274 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20021
20034
200413
200510
200612
20077
200812
20099
20104
20119
201213
20136
201410
201513
201612
201720
201810
20196
202021
202114
202216
202311
20247
202513
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed138
Recruiting51
Terminated37
Active, not recruiting35
Unknown status5
Withdrawn2
Not yet recruiting2
Suspended1
Enrolling by invitation1
Available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)35
Memorial Sloan Kettering Cancer Center22
M.D. Anderson Cancer Center15
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)8
Dana-Farber Cancer Institute6
Mayo Clinic6
Eisai Inc.5
Medstar Health Research Institute5
Pfizer5
Eli Lilly and Company4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms274
Breast Neoplasms52
Thyroid Cancer, Papillary47
Melanoma45
Head and Neck Neoplasms43
Carcinoma, Non-Small-Cell Lung39
Prostatic Neoplasms37
Lung Neoplasms36
Sarcoma36
Adenocarcinoma, Follicular34

Trials

Showing 1 to 25 of 274. Each trial links to its page on Pharma Observatory.

174 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.